• Explore /
  • Poster
  • / Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08).

Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients with locally advanced, K-ras-mutated rectal cancer (LARC): A phase I/II trial (SAKK 41/08).

Abstract Poster

Authors

Roger Von Moos

Roger Von Moos

Kantonsspital Graubünden, Chur, Switzerland

Roger Von Moos , Dieter Koeberle , Ralph C. Winterhalder , Richard Cathomas , Roman Ignaz Inauen , Daniel Rudolf Zwahlen , Arnaud Roth , Daniel Helbling , Oliver Gautschi , Daniela Baertschi , Reto Kuehne , Thomas Von Briel , Anja Grzesiczek , Panagiotis Samaras , Attila Kollar , Dirk Klingbiel , Kathrin Zaugg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00869570

Citation

J Clin Oncol 30, 2012 (suppl; abstr 3595)

DOI

10.1200/jco.2012.30.15_suppl.3595

Abstract #

3595

Poster Bd #

33H

Abstract Disclosures

Similar Posters

First Author: Roger Von Moos

First Author: Brian G. Czito

First Author: Gopi Kesaria Prithviraj

First Author: Michael Michael